Annual Total Liabilities
$2.15 M
-$61.00 K-2.76%
31 October 2023
Summary:
Anixa Biosciences annual total liabilities is currently $2.15 million, with the most recent change of -$61.00 thousand (-2.76%) on 31 October 2023. During the last 3 years, it has risen by +$661.00 thousand (+44.36%). ANIX annual total liabilities is now -75.45% below its all-time high of $8.76 million, reached on 31 October 2013.ANIX Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Total Liabilities
$2.22 M
+$443.00 K+24.97%
01 July 2024
Summary:
Anixa Biosciences quarterly total liabilities is currently $2.22 million, with the most recent change of +$443.00 thousand (+24.97%) on 01 July 2024. Over the past year, it has increased by +$66.00 thousand (+3.07%). ANIX quarterly total liabilities is now -86.14% below its all-time high of $16.00 million, reached on 31 January 2014.ANIX Quarterly Total Liabilities Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
ANIX Total Liabilities Performance
PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
---|---|---|
1 y1 year | - | +3.1% |
3 y3 years | +44.4% | +48.8% |
5 y5 years | +45.2% | +49.7% |
ANIX Total Liabilities High & Low
PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
---|---|---|---|---|---|
3 y | 3 years | -2.8% | +44.4% | at high | +59.4% |
5 y | 5 years | -2.8% | +81.0% | at high | +101.1% |
alltime | all time | -75.5% | +2051.0% | -86.1% | +2117.0% |
Anixa Biosciences Total Liabilities History
Date | Annual | Quarterly |
---|---|---|
July 2024 | - | $2.22 M(+25.0%) |
Apr 2024 | - | $1.77 M(+0.3%) |
Jan 2024 | - | $1.77 M(-17.8%) |
Oct 2023 | $2.15 M(-2.8%) | $2.15 M(+7.9%) |
July 2023 | - | $1.99 M(+18.2%) |
Apr 2023 | - | $1.69 M(+20.9%) |
Jan 2023 | - | $1.39 M(-37.0%) |
Oct 2022 | $2.21 M(+48.5%) | $2.21 M(+33.6%) |
July 2022 | - | $1.66 M(+19.1%) |
Apr 2022 | - | $1.39 M(-30.3%) |
Jan 2022 | - | $2.00 M(+34.0%) |
Oct 2021 | $1.49 M(+25.4%) | $1.49 M(+23.3%) |
July 2021 | - | $1.21 M(-16.3%) |
Apr 2021 | - | $1.44 M(-5.4%) |
Jan 2021 | - | $1.53 M(+28.3%) |
Oct 2020 | $1.19 M(-19.8%) | $1.19 M(-2.9%) |
July 2020 | - | $1.22 M(+11.0%) |
Apr 2020 | - | $1.10 M(-5.5%) |
Jan 2020 | - | $1.17 M(-21.3%) |
Oct 2019 | $1.48 M(+17.1%) | $1.48 M(+2.6%) |
July 2019 | - | $1.44 M(-9.5%) |
Apr 2019 | - | $1.60 M(+20.2%) |
Jan 2019 | - | $1.33 M(+4.9%) |
Oct 2018 | $1.27 M(+42.2%) | $1.27 M(+12.0%) |
July 2018 | - | $1.13 M(-15.7%) |
Apr 2018 | - | $1.34 M(+23.3%) |
Jan 2018 | - | $1.09 M(+22.2%) |
Oct 2017 | $889.50 K(-80.8%) | $889.50 K(-69.6%) |
July 2017 | - | $2.93 M(-20.0%) |
Apr 2017 | - | $3.66 M(-54.5%) |
Jan 2017 | - | $8.04 M(+73.2%) |
Oct 2016 | $4.64 M(+8.4%) | $4.64 M(+0.8%) |
July 2016 | - | $4.60 M(-0.9%) |
Apr 2016 | - | $4.65 M(-8.1%) |
Jan 2016 | - | $5.06 M(+18.1%) |
Oct 2015 | $4.28 M(-15.1%) | $4.28 M(+0.0%) |
July 2015 | - | $4.28 M(+3.4%) |
Apr 2015 | - | $4.14 M(-17.4%) |
Jan 2015 | - | $5.01 M(-0.7%) |
Oct 2014 | $5.05 M(-42.4%) | $5.05 M(-61.9%) |
July 2014 | - | $13.25 M(-13.7%) |
Apr 2014 | - | $15.35 M(-4.1%) |
Jan 2014 | - | $16.00 M(+82.6%) |
Oct 2013 | $8.76 M(+27.8%) | $8.76 M(+2.5%) |
July 2013 | - | $8.55 M(-2.9%) |
Apr 2013 | - | $8.80 M(-0.5%) |
Jan 2013 | - | $8.85 M(+29.1%) |
Oct 2012 | $6.85 M(-9.7%) | $6.85 M(+1.1%) |
July 2012 | - | $6.78 M(-4.9%) |
Apr 2012 | - | $7.13 M(-2.2%) |
Jan 2012 | - | $7.29 M(-3.9%) |
Oct 2011 | $7.59 M(+39.2%) | $7.59 M(-4.3%) |
July 2011 | - | $7.93 M(+42.8%) |
Apr 2011 | - | $5.55 M(-0.5%) |
Jan 2011 | - | $5.58 M(+2.4%) |
Oct 2010 | $5.45 M(+1.0%) | $5.45 M(-0.8%) |
July 2010 | - | $5.49 M(+1.9%) |
Apr 2010 | - | $5.39 M(-0.0%) |
Jan 2010 | - | $5.39 M(-0.1%) |
Oct 2009 | $5.40 M(-6.4%) | $5.40 M(+3.5%) |
July 2009 | - | $5.21 M(-4.5%) |
Apr 2009 | - | $5.46 M(-4.0%) |
Jan 2009 | - | $5.68 M(-1.5%) |
Oct 2008 | $5.77 M(+749.7%) | $5.77 M(-12.5%) |
July 2008 | - | $6.59 M(+20.3%) |
Apr 2008 | - | $5.48 M(-1.9%) |
Jan 2008 | - | $5.59 M(+723.0%) |
Oct 2007 | $678.80 K(+16.7%) | $678.80 K(+111.9%) |
July 2007 | - | $320.30 K(-2.3%) |
Apr 2007 | - | $327.80 K(-10.7%) |
Jan 2007 | - | $367.10 K(-36.9%) |
Oct 2006 | $581.80 K | $581.80 K(+99.2%) |
Date | Annual | Quarterly |
---|---|---|
July 2006 | - | $292.00 K(-21.4%) |
Apr 2006 | - | $371.70 K(-21.3%) |
Jan 2006 | - | $472.40 K(+35.7%) |
Oct 2005 | $348.20 K(-21.4%) | $348.20 K(+28.9%) |
July 2005 | - | $270.10 K(-7.8%) |
Apr 2005 | - | $292.90 K(-30.7%) |
Jan 2005 | - | $422.40 K(-4.7%) |
Oct 2004 | $443.10 K(+29.4%) | $443.10 K(+23.0%) |
July 2004 | - | $360.20 K(-11.8%) |
Apr 2004 | - | $408.30 K(+6.5%) |
Jan 2004 | - | $383.30 K(+12.0%) |
Oct 2003 | $342.30 K(-17.3%) | $342.30 K(-12.2%) |
July 2003 | - | $389.80 K(-7.5%) |
Apr 2003 | - | $421.20 K(-8.8%) |
Jan 2003 | - | $461.60 K(+11.5%) |
Oct 2002 | $414.00 K(-82.7%) | $414.00 K(+5.2%) |
July 2002 | - | $393.70 K(-74.4%) |
Apr 2002 | - | $1.53 M(-62.7%) |
Jan 2002 | - | $4.11 M(+71.7%) |
Oct 2001 | $2.40 M(+79.2%) | $2.40 M(-25.2%) |
July 2001 | - | $3.20 M(+179.2%) |
Apr 2001 | - | $1.15 M(-9.7%) |
Jan 2001 | - | $1.27 M(-5.1%) |
Oct 2000 | $1.34 M(-21.4%) | $1.34 M(-42.8%) |
July 2000 | - | $2.34 M(+12.5%) |
Apr 2000 | - | $2.08 M(+3.8%) |
Jan 2000 | - | $2.00 M(+17.6%) |
Oct 1999 | $1.70 M(+21.4%) | $1.70 M(+6.3%) |
July 1999 | - | $1.60 M(+23.1%) |
Apr 1999 | - | $1.30 M(-7.1%) |
Jan 1999 | - | $1.40 M(0.0%) |
Oct 1998 | $1.40 M(+16.7%) | $1.40 M(0.0%) |
July 1998 | - | $1.40 M(+27.3%) |
Apr 1998 | - | $1.10 M(-15.4%) |
Jan 1998 | - | $1.30 M(+8.3%) |
Oct 1997 | $1.20 M(-36.8%) | $1.20 M(-20.0%) |
July 1997 | - | $1.50 M(+15.4%) |
Apr 1997 | - | $1.30 M(-13.3%) |
Jan 1997 | - | $1.50 M(-21.1%) |
Oct 1996 | $1.90 M(+533.3%) | $1.90 M(+137.5%) |
July 1996 | - | $800.00 K(+60.0%) |
Apr 1996 | - | $500.00 K(0.0%) |
Jan 1996 | - | $500.00 K(+66.7%) |
Oct 1995 | $300.00 K(+50.0%) | $300.00 K(+50.0%) |
July 1995 | - | $200.00 K(-33.3%) |
Apr 1995 | - | $300.00 K(0.0%) |
Jan 1995 | - | $300.00 K(+50.0%) |
Oct 1994 | $200.00 K(-60.0%) | $200.00 K(-33.3%) |
July 1994 | - | $300.00 K(-25.0%) |
Apr 1994 | - | $400.00 K(-33.3%) |
Jan 1994 | - | $600.00 K(+20.0%) |
Oct 1993 | $500.00 K(+66.7%) | $500.00 K(+66.7%) |
July 1993 | - | $300.00 K(-25.0%) |
Apr 1993 | - | $400.00 K(+33.3%) |
Jan 1993 | - | $300.00 K(0.0%) |
Oct 1992 | $300.00 K(+200.0%) | $300.00 K(+50.0%) |
July 1992 | - | $200.00 K(0.0%) |
Apr 1992 | - | $200.00 K(0.0%) |
Jan 1992 | - | $200.00 K(+100.0%) |
Oct 1991 | $100.00 K(0.0%) | $100.00 K(0.0%) |
July 1991 | - | $100.00 K(0.0%) |
Apr 1991 | - | $100.00 K(0.0%) |
Jan 1991 | - | $100.00 K(0.0%) |
Oct 1990 | $100.00 K(0.0%) | $100.00 K(0.0%) |
July 1990 | - | $100.00 K(0.0%) |
Apr 1990 | - | $100.00 K(0.0%) |
Jan 1990 | - | $100.00 K(0.0%) |
Oct 1989 | $100.00 K(0.0%) | $100.00 K(0.0%) |
Oct 1988 | $100.00 K(0.0%) | $100.00 K(0.0%) |
Oct 1987 | $100.00 K(-50.0%) | $100.00 K(-50.0%) |
Oct 1986 | $200.00 K(0.0%) | $200.00 K(0.0%) |
Oct 1985 | $200.00 K(0.0%) | $200.00 K(0.0%) |
Oct 1984 | $200.00 K | $200.00 K |
FAQ
- What is Anixa Biosciences annual total liabilities?
- What is the all time high annual total liabilities for Anixa Biosciences?
- What is Anixa Biosciences quarterly total liabilities?
- What is the all time high quarterly total liabilities for Anixa Biosciences?
- What is Anixa Biosciences quarterly total liabilities year-on-year change?
What is Anixa Biosciences annual total liabilities?
The current annual total liabilities of ANIX is $2.15 M
What is the all time high annual total liabilities for Anixa Biosciences?
Anixa Biosciences all-time high annual total liabilities is $8.76 M
What is Anixa Biosciences quarterly total liabilities?
The current quarterly total liabilities of ANIX is $2.22 M
What is the all time high quarterly total liabilities for Anixa Biosciences?
Anixa Biosciences all-time high quarterly total liabilities is $16.00 M
What is Anixa Biosciences quarterly total liabilities year-on-year change?
Over the past year, ANIX quarterly total liabilities has changed by +$66.00 K (+3.07%)